Skip to main content
. 2015 Jan 28;26(5):958–966. doi: 10.1093/annonc/mdv036

Figure 1.

Figure 1.

Kaplan–Meier plots comparing OS for patients enrolled on trials in different treatment eras. Patients with AIDS-related lymphomas who had (A) DLCBL, (B) BL/BLL, (C) CD4 <50 cells/mm3 or (D) CD4 ≥50 cells/mm3 achieved significantly longer overall survival when treated in later treatment eras.